Pelthos Therapeutics Inc (PTHS): Next-Year EPS Estimate 83.89%
As of 2026-06-11, Pelthos Therapeutics Inc (PTHS) has a next-year EPS growth estimate of 83.89%.
On 2026-05-17, analyst consensus for PTHS's next-year EPS growth shifted from 84.87% to 83.89% — a negative change of 0.98 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at 55.07%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 83.89%
- EPS growth this year
- 55.07%
- EPS next quarter (est)
- -$2.82
- Last price
- $28.72
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 83.89% | 55.07% | -$2.82 | $28.72 |
| 2026-06-10 | 83.89% | 55.07% | -$2.82 | $27.42 |
| 2026-06-09 | 83.89% | 55.07% | -$2.82 | $26.90 |
| 2026-06-08 | 83.89% | 55.07% | -$2.82 | $26.30 |
| 2026-06-07 | 83.89% | 55.07% | -$2.82 | $25.55 |
| 2026-06-04 | 83.89% | 55.07% | -$2.82 | $25.86 |
| 2026-06-03 | 83.89% | 55.07% | -$2.82 | $25.88 |
| 2026-06-02 | 83.89% | 55.07% | -$2.82 | $26.00 |
| 2026-06-01 | 83.89% | 55.07% | -$2.82 | $26.20 |
| 2026-05-31 | 83.89% | 55.07% | -$2.82 | $26.47 |
| 2026-05-28 | 83.89% | 55.07% | -$2.82 | $25.80 |
| 2026-05-27 | 83.89% | 55.07% | -$2.82 | $26.96 |
| 2026-05-26 | 83.89% | 55.07% | -$2.82 | $27.17 |
| 2026-05-25 | 83.89% | 55.07% | -$2.82 | $26.66 |
| 2026-05-24 | 83.89% | 55.07% | -$2.82 | $26.66 |
| 2026-05-21 | 83.89% | 55.07% | -$2.82 | $27.10 |
| 2026-05-20 | 83.89% | 55.07% | -$2.82 | $27.11 |
| 2026-05-19 | 83.89% | 55.07% | -$2.82 | $27.00 |
| 2026-05-18 | 83.89% | 55.07% | -$2.82 | $26.15 |
| 2026-05-17 | 83.89% | 55.07% | -$2.82 | $26.72 |
| 2026-05-14 | 84.87% | 55.92% | -$2.62 | $27.69 |
| 2026-05-13 | 89.40% | 57.58% | -$3.45 | $26.70 |
| 2026-05-12 | 89.40% | 57.58% | -$3.45 | $27.24 |
| 2026-05-11 | 89.40% | 57.58% | -$3.45 | $26.85 |
| 2026-05-10 | 89.40% | 57.58% | -$3.45 | $25.50 |
| 2026-05-07 | 89.40% | 57.58% | -$3.45 | $25.03 |
| 2026-05-06 | 89.40% | 57.58% | -$3.45 | $25.00 |
| 2026-05-05 | 89.40% | 57.58% | -$3.45 | $25.45 |
| 2026-05-04 | 89.40% | 57.58% | -$3.45 | $24.82 |
| 2026-05-03 | 89.40% | 57.58% | -$3.45 | $25.00 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Pelthos Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Pelthos Therapeutics Inc (PTHS) has a next-year EPS growth estimate of 83.89%, based on analyst consensus.
When was the latest EPS estimate revision for PTHS?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 84.87% to 83.89%.
What sector and industry does Pelthos Therapeutics Inc belong to?▾
Pelthos Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PTHS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Pelthos Therapeutics Inc (PTHS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports